PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma

被引:69
作者
Ye, Yan [1 ,2 ]
Jin, Lei [3 ,4 ]
Wilmott, James S. [3 ,5 ,6 ]
Hu, Wang Lai [7 ,8 ]
Yosufi, Benafsha [3 ,5 ,6 ]
Thorne, Rick F. [9 ]
Liu, Tao [10 ]
Rizos, Helen [3 ,11 ]
Yan, Xu Guang [9 ]
Dong, Li [1 ,3 ]
Tay, Kwang Hong [1 ,3 ]
Tseng, Hsin-Yi [1 ,3 ]
Guo, Su Tang [12 ]
de Bock, Charles E. [9 ]
Jiang, Chen Chen [1 ,3 ]
Wang, Chun Yan [12 ]
Wu, Mian [7 ,8 ]
Zhang, Lin Jie [2 ]
Hersey, Peter [3 ,4 ]
Scolyer, Richard A. [3 ,5 ,6 ]
Zhang, Xu Dong [1 ,3 ,12 ]
机构
[1] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia
[2] Anhui Med Univ, Dept Immunol, Hefei 230032, Anhui, Peoples R China
[3] Melanoma Inst Australia, Sydney, NSW 2060, Australia
[4] Univ Sydney, Kolling Inst Med Res, Immunol & Oncol Unit, Sydney, NSW 2065, Australia
[5] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia
[6] Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia
[7] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China
[8] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China
[9] Univ Newcastle, Canc Res Unit, Newcastle, NSW 2308, Australia
[10] Univ New S Wales, Childrens Canc Inst Australia Med Res, Sydney, NSW 2052, Australia
[11] Univ Sydney, Westmead Millennium Inst, Westmead Hosp, Westmead Inst Canc Res, Sydney, NSW 2000, Australia
[12] Shanxi Canc Hosp & Inst, Dept Mol Biol, Taiyuan 030013, Peoples R China
来源
NATURE COMMUNICATIONS | 2013年 / 4卷
基金
澳大利亚国家健康与医学研究理事会; 中国国家自然科学基金; 英国医学研究理事会;
关键词
UP-REGULATION; EXPRESSION; GENE; PHOSPHORYLATION; AKT; PATHWAY; KINASE; TARGET; DOWNSTREAM; ACTIVATION;
D O I
10.1038/ncomms2489
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inositol polyphosphate 5-phosphatases can terminate downstream signalling of phosphatidylinositol-3 kinase; however, their biological role in the pathogenesis of cancer is controversial. Here we report that the inositol polyphosphate 5-phosphatase, phosphatidylinositol 4,5-bisphosphate 5-phosphatase, has a tumour suppressive role in melanoma. Although it is commonly downregulated in melanoma, overexpression of phosphatidylinositol 4,5-bisphosphate 5-phosphatase blocks Akt activation, inhibits proliferation and undermines survival of melanoma cells in vitro, and retards melanoma growth in a xenograft model. In contrast, knockdown of phosphatidylinositol 4,5-bisphosphate 5-phosphatase results in increased proliferation and anchorage-independent growth of melanocytes. Although DNA copy number loss is responsible for downregulation of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in a proportion of melanomas, histone hypoacetylation mediated by histone deacetylases HDAC2 and HDAC3 through binding to the transcription factor Sp1 at the PIB5PA gene promoter appears to be another commonly involved mechanism. Collectively, these results establish the tumour suppressive role of phosphatidylinositol 4,5-bisphosphate 5-phosphatase and reveal mechanisms involved in its downregulation in melanoma.
引用
收藏
页数:15
相关论文
共 58 条
  • [1] Multiplexed assays for detection of mutations in PIK3CA
    Board, Ruth E.
    Thelwell, Nicola J.
    Ravetto, Paul F.
    Little, Stephen
    Ranson, Malcolm
    Dive, Caro-Line
    Hughes, Andrw
    Whitcombe, David
    [J]. CLINICAL CHEMISTRY, 2008, 54 (04) : 757 - 760
  • [2] Anticancer activities of histone deacetylase inhibitors
    Bolden, Jessica E.
    Peart, Melissa J.
    Johnstone, Ricky W.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) : 769 - 784
  • [3] PIKKing on PKB: regulation of PKB activity by phosphorylation
    Bozulic, Lana
    Hemmings, Brian A.
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) : 256 - 261
  • [4] PTEN Level in Tumor Suppression: How Much Is Too Little?
    Carracedo, Arkaitz
    Alimonti, Andrea
    Pandolfi, Pier Paolo
    [J]. CANCER RESEARCH, 2011, 71 (03) : 629 - 633
  • [5] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2507 - 2516
  • [6] Akt and mutant V600EB-Raf cooperate to promote early melanoma development
    Cheung, Mitchefl
    Sharma, Arati
    Madhunapantula, SubbaRao V.
    Robertson, Gavin P.
    [J]. CANCER RESEARCH, 2008, 68 (09) : 3429 - 3439
  • [7] The PI3K Pathway As Drug Target in Human Cancer
    Courtney, Kevin D.
    Corcoran, Ryan B.
    Engelman, Jeffrey A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 1075 - 1083
  • [8] Somatic activation of KIT in distinct subtypes of melanoma
    Curtin, John A.
    Busam, Klaus
    Pinkel, Daniel
    Bastian, Boris C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) : 4340 - 4346
  • [9] PI3-kinase subunits are infrequent somatic targets in melanoma
    Curtin, John A.
    Stark, Mitchell S.
    Pinkel, Daniel
    Hayward, Nicholas K.
    Bastian, Boris C.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (07) : 1660 - 1663
  • [10] BrafV600E cooperates with Pten loss to induce metastatic melanoma
    Dankort, David
    Curley, David P.
    Cartlidge, Robert A.
    Nelson, Betsy
    Karnezis, Anthony N.
    Damsky, William E., Jr.
    You, Mingjian J.
    DePinho, Ronald A.
    McMahon, Martin
    Bosenberg, Marcus
    [J]. NATURE GENETICS, 2009, 41 (05) : 544 - 552